Search results
Immunotherapy may boost survival after lung cancer surgery
UPI· 5 days agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 5 days agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
Lung cancer is the deadliest of all cancers, and screening could save many lives − if more people...
PhillyVoice.com· 5 days agoFor comparison, the screening rate in 2021 for colon cancer was 72%, and the rate for breast cancer...
How to spot the signs and symptoms of throat cancer
Daily Telegraph· 6 days ago“The telltale signs are not generally silent but can take a while to be noticed,” warns Dr Naomi Vaughan, a GP with a practice in Harrow, north-west...
Here’s what to know about innovative treatment Dr. Richard Scolyer used on his own deadly cancer: ‘A...
NY Post via Yahoo News· 5 days agoScolyer, 57, was diagnosed with a type of cancer called glioblastoma, a brain tumor that is...
Cancer is increasingly survivable – but it shouldn’t depend on your ability to ‘wrangle’ the health...
The Conversation· 7 days agoOne in three of us will develop cancer at some point in our lives. A large and growing proportion of people diagnosed with cancer are living with it, rather ...
For most, pancreatic cancer is a deadly diagnosis. How one Fort Worth man beat the odds
Fort Worth Star-Telegram· 1 day agoA retired lieutenant colonel in the Air Force beat the odds when he was diagnosed with pancreatic cancer last year.
DDW 2024: Cedars-Sinai Experts Share Latest Resear | Newswise
Newswise· 6 days agoCedars-Sinai digestive and liver diseases physicians and scientists will share their latest research at the annual Digestive Disease Week meeting, that tak
Neuroendocrine pancreatic cancer: An overview
Medical News Today· 6 days agoLearn about the symptoms and causes of pancreatic neuroendocrine tumors. This article also discusses diagnosis, treatment options, and more.
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 2 days agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast ...